Prosecution Insights
Last updated: April 19, 2026
Application No. 17/924,388

Thermoplastic Elastomer Compositions for Use in Pharmaceutical Articles

Final Rejection §103§112
Filed
Nov 10, 2022
Examiner
CAI, WENWEN
Art Unit
1763
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Celanese International Corporation
OA Round
3 (Final)
60%
Grant Probability
Moderate
4-5
OA Rounds
3y 2m
To Grant
80%
With Interview

Examiner Intelligence

Grants 60% of resolved cases
60%
Career Allow Rate
509 granted / 850 resolved
-5.1% vs TC avg
Strong +20% interview lift
Without
With
+19.8%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
74 currently pending
Career history
924
Total Applications
across all art units

Statute-Specific Performance

§101
0.8%
-39.2% vs TC avg
§103
43.6%
+3.6% vs TC avg
§102
17.4%
-22.6% vs TC avg
§112
27.9%
-12.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 850 resolved cases

Office Action

§103 §112
DETAILED ACTION The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Final rejection issued on 1/15/2026 is withdrawn and a new ground of rejection is set forth below. Response to Amendment The amendment of claims 1, 3 are supported by the specification. Any rejections and/or objections made in the previous Office action and not repeated below are hereby withdrawn. The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office action. The new grounds of rejection set forth below are necessitated by applicant's amendment filed on 12/10/2025. Thus, the following action is properly made final. Claim Rejections - 35 USC § 112 Claims 1-3, 8-9 rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor, or for pre-AIA the applicant regards as the invention. Claim 1 recites “a cured thermoplastic elastomer composition… comprising one or more brominated isobutylene paramethyl-styrene terpolymers, …… wherein the thermoplastic elastomer composition is cured using…”. It is noted that terpolymer and cured terpolymer are in an intermediate-final product relationship. If the uncured composition comprises terpolymer then cured composition should comprise cured terpolymer. Clarification is required. For purposes of expediting prosecution, the claim is interpreted as “a cured …composition obtained by curing terpolymer, polypropylene and a curing system.” Claim 1 recites “a cured thermoplastic elastomer composition comprising one or more brominated isobutylene paramethyl-styrene terpolymers, …… wherein the thermoplastic elastomer composition is cured using…”. It is unclear if the thermoplastic elastomer composition refers to cured composition or uncured composition. Clarification is required. For purposes of expediting prosecution, the claim is interpreted as “a cured …composition obtained by curing terpolymer, polypropylene and a curing system.” Claim 1 recites “obtained by curing a terpolymer……one or more brominated isobutylene paramethyl-styrene terpolymer”, it is unclear whether they refer to the same ingredient. For purposes of expediting prosecution, they are interpreted as the same. Claim 1 recites “obtained by curing a terpolymer, a polypropylene……a polypropylene homopolymer”, it is unclear whether they refer to the same ingredient. For purposes of expediting prosecution, they are interpreted as the same. Claim Rejections - 35 USC § 103 Claims 1-3, 8-9 is/are rejected under 35 U.S.C. 103 as being unpatentable over Takacs et al (US 2020/0347209) in view of Yu et al (US 5,051,477). Takacs teaches an at least partially cured thermoplastic vulcanizate composition comprising a brominated isobutylene paramethyl styrene terpolymer, and 10-200 phr of a polypropylene homopolymer, 10-150 phr of process oil such as isobutylene copolymer Indopol [0025-0028, 0044-0050, 0065-0066, 0081, 0084, 0092 tables 2-3]. The composition is cured by a curative such as phenolic resin, metal oxide, stearic, hydrosilylation, peroxide in an amount of 0.5-15phr [0050-0057]. Case law holds that in the case where the claimed ranges “overlap or lie inside ranges disclosed by the prior art” a prima facie case of obviousness exists. In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976); In re Woodruff, 919 F.2d 1575, 16 USPQ2d 1934 (Fed. Cir. 1990). A specific gravity of 0.93-0.95 and a Shore A hardness of 85.3 are desired for the composition (table 5). Takacs does not teach the curative is an amine compound. However, Yu discloses a brominated isobutylene paramethyl styrene terpolymer composition and teaches conventional curing agent zinc oxide and peroxide may cause the degradation of some components, while conventional curing agent hexamethylene diamine carbamate is a better choice (7:16-45). Therefore, it would have been obvious to one of ordinary skill in the art at the time the invention was made to utilize hexamethylene diamine carbamate as the curing agent for the composition of Takacs because the results of a simple substitution of one known element for another would have been predictable. Response to Arguments Applicant’s arguments have been considered but are moot in view of the new ground(s) of rejection. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any extension fee pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to WENWEN CAI whose telephone number is (571)270-3590. The examiner can normally be reached on M-F 9am-6pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Joseph Del Sole can be reached on (571)272-1130. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /WENWEN CAI/ Primary Examiner, Art Unit 1763
Read full office action

Prosecution Timeline

Nov 10, 2022
Application Filed
Sep 08, 2025
Non-Final Rejection — §103, §112
Dec 10, 2025
Response Filed
Jan 13, 2026
Final Rejection — §103, §112
Mar 16, 2026
Response after Non-Final Action
Mar 19, 2026
Final Rejection — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12600886
RESINS FOR ADHESIVE BONDING OF FABRICS
2y 5m to grant Granted Apr 14, 2026
Patent 12590201
DEGRADATION PROMOTER FOR ALIPHATIC POLYESTER BIODEGRADABLE RESIN, BIODEGRADABLE RESIN COMPOSITION, AND METHOD FOR PROMOTING DEGRADATION OF ALIPHATIC POLYESTER BIODEGRADABLE RESIN
2y 5m to grant Granted Mar 31, 2026
Patent 12559592
BRANCHED AMORPHOUS POLYAMIDE (CO)POLYMERS AND METHODS OF MAKING AND USING SAME
2y 5m to grant Granted Feb 24, 2026
Patent 12552956
PHOTOPOLYMERIZABLE TYPE DENTAL SURFACE COATING COMPOSITION
2y 5m to grant Granted Feb 17, 2026
Patent 12534556
CURABLE COMPOSITION, CURED ARTICLE USING SAME, AND METHOD FOR PRODUCING CURED ARTICLE
2y 5m to grant Granted Jan 27, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

4-5
Expected OA Rounds
60%
Grant Probability
80%
With Interview (+19.8%)
3y 2m
Median Time to Grant
High
PTA Risk
Based on 850 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month